|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
decreases expression |
ISO |
myristicin results in decreased expression of ABL1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 3:35,377,587...35,480,843
|
|
G |
Ankrd17 |
ankyrin repeat domain 17 |
decreases expression |
ISO |
myristicin results in decreased expression of ANKRD17 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr14:18,007,342...18,145,980
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
myristicin results in decreased expression of ATM mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 8:62,724,939...62,829,040
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
myristicin results in increased expression of BAX mRNA |
CTD |
PMID:29174417 |
|
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
myristicin results in decreased expression of BCL2 mRNA |
CTD |
PMID:29174417 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
myristicin results in decreased expression of BRCA1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr10:86,917,693...86,978,012
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
decreases expression |
ISO |
myristicin results in decreased expression of BTG2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr13:48,083,931...48,087,690
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
myristicin results in increased activity of CASP3 protein |
CTD |
PMID:24792648 |
|
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
myristicin results in increased activity of CASP9 protein |
CTD |
PMID:29174417 |
|
|
|
G |
Cdk7 |
cyclin-dependent kinase 7 |
increases expression |
ISO |
myristicin results in increased expression of CDK7 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 2:33,574,623...33,599,485
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
myristicin results in decreased expression of CHEK2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr12:51,448,838...51,481,159
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
myristicin results in increased expression of CYP1A1 mRNA myristicin results in increased expression of and results in increased activity of CYP1A1 protein |
CTD |
PMID:9168900 |
|
NCBI chr 8:66,991,940...66,998,014
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects oxidation multiple interactions decreases activity |
ISO |
CYP1A2 protein affects the oxidation of myristicin Glutathione inhibits the reaction [myristicin results in decreased activity of CYP1A2 protein] |
CTD |
PMID:12523956 PMID:26091900 |
|
NCBI chr 8:66,971,261...66,978,149
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
affects oxidation |
ISO |
CYP3A4 protein affects the oxidation of myristicin |
CTD |
PMID:12523956 |
|
NCBI chr12:14,321,771...14,343,886
|
|
G |
Dmc1 |
DNA meiotic recombinase 1 |
decreases expression |
ISO |
myristicin results in decreased expression of DMC1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 7:111,124,888...111,167,465
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
decreases expression |
ISO |
myristicin results in decreased expression of ERCC1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:78,971,310...79,007,963
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
decreases expression |
ISO |
myristicin results in decreased expression of ERCC2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:88,161,342...88,175,102
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
myristicin results in decreased expression of FEN1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:216,270,016...216,274,873
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
decreases expression |
ISO |
myristicin results in decreased expression of GADD45A mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 4:97,484,497...97,486,799
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
ISO |
myristicin results in decreased expression of GADD45G mRNA |
CTD |
PMID:24792648 |
|
NCBI chr17:13,528,606...13,530,351
|
|
G |
Hus1 |
HUS1 checkpoint clamp component |
decreases expression |
ISO |
myristicin results in decreased expression of HUS1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr14:83,688,702...83,703,466
|
|
G |
Ighmbp2 |
immunoglobulin mu DNA binding protein 2 |
decreases expression |
ISO |
myristicin results in decreased expression of IGHMBP2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:200,506,641...200,529,293
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
decreases expression |
ISO |
myristicin results in decreased expression of MAP3K20 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 3:77,538,146...77,697,540
|
|
G |
Mapk12 |
mitogen-activated protein kinase 12 |
decreases expression |
ISO |
myristicin results in decreased expression of MAPK12 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 7:122,085,647...122,096,307
|
|
G |
Mlh3 |
mutL homolog 3 |
decreases expression |
ISO |
myristicin results in decreased expression of MLH3 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 6:104,881,483...104,917,686
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
decreases expression |
ISO |
myristicin results in decreased expression of MRE11 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 8:19,900,211...19,961,906
|
|
G |
Msh3 |
mutS homolog 3 |
decreases expression |
ISO |
myristicin results in decreased expression of MSH3 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 2:25,179,400...25,320,857
|
|
G |
Mutyh |
mutY DNA glycosylase |
decreases expression |
ISO |
myristicin results in decreased expression of MUTYH mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 5:130,274,034...130,286,149
|
|
G |
N4bp2 |
NEDD4 binding protein 2 |
decreases expression |
ISO |
myristicin results in decreased expression of N4BP2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr14:42,696,415...42,819,535
|
|
G |
Nbn |
nibrin |
decreases expression |
ISO |
myristicin results in decreased expression of NBN mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 5:34,256,678...34,291,163
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases expression |
ISO |
myristicin results in decreased expression of OGG1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 4:148,030,237...148,037,599
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
myristicin results in increased cleavage of PARP1 protein |
CTD |
PMID:24792648 |
|
NCBI chr13:94,839,484...94,871,295
|
|
G |
Pms2 |
PMS1 homolog 2, mismatch repair system component |
decreases expression |
ISO |
myristicin results in decreased expression of PMS2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr12:10,676,818...10,701,161
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
myristicin results in decreased expression of PNKP mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:104,476,801...104,483,409
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases expression |
ISO |
myristicin results in decreased expression of PPP1R15A mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:105,136,521...105,139,596
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
myristicin results in decreased expression of PRKDC mRNA |
CTD |
PMID:24792648 |
|
NCBI chr11:98,544,952...98,762,499
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
decreases expression |
ISO |
myristicin results in decreased expression of RAD50 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr10:37,809,353...37,861,309
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
ISO |
myristicin results in decreased expression of RAD51 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 3:126,554,210...126,578,888
|
|
G |
Rad51b |
RAD51 paralog B |
decreases expression |
ISO |
myristicin results in decreased expression of RAD51B mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 6:98,096,525...98,640,988
|
|
G |
Rad9a |
RAD9 checkpoint clamp component A |
decreases expression |
ISO |
myristicin results in decreased expression of RAD9A mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 1:201,488,511...201,553,582
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
decreases expression |
ISO |
myristicin results in decreased expression of REV1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 9:47,773,907...47,847,554
|
|
G |
Sesn1 |
sestrin 1 |
decreases expression |
ISO |
myristicin results in decreased expression of SESN1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr20:46,876,918...46,970,010
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
decreases expression |
ISO |
myristicin results in decreased expression of SMC1A mRNA |
CTD |
PMID:24792648 |
|
NCBI chr X:24,582,732...24,627,462
|
|
G |
Tp73 |
tumor protein p73 |
decreases expression |
ISO |
myristicin results in decreased expression of TP73 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 5:169,903,801...169,988,075
|
|
G |
Trex1 |
three prime repair exonuclease 1 |
decreases expression |
ISO |
myristicin results in decreased expression of TREX1 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 8:118,585,082...118,586,382
|
|
G |
Xrcc2 |
X-ray repair cross complementing 2 |
decreases expression |
ISO |
myristicin results in decreased expression of XRCC2 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 4:10,157,130...10,237,089
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
decreases expression increases expression |
ISO |
myristicin results in decreased expression of XRCC3 mRNA myristicin results in increased expression of XRCC3 mRNA |
CTD |
PMID:24792648 |
|
NCBI chr 6:136,684,558...136,694,822
|
|